Genetic and regulatory architecture of Alzheimer's disease in the APOE region

Apolipoprotein E (APOE) ε2 and ε4 alleles encoded by rs7412 and rs429358 polymorphisms, respectively, are landmark contra and pro “risk” factors for Alzheimer's disease (AD).

• Publication year

  2020

• Venue

  Alzheimer's & Dementia

• Publication date

  2020-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/dad2.12008PMID 32211503PMCID 7085286
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic and regulatory architecture of Alzheimer's disease in the APOE region

  2020cited by this paper
• Lowering of Amyloid-Beta by β-Secretase Inhibitors - Some Informative Failures.

  2019cited by this paper
• Apolipoprotein E region molecular signatures of Alzheimer's disease

  2018cited by this paper
• Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA‐AA Research Framework

  2018cited by this paper
• PPARs: Key Regulators of Airway Inflammation and Potential Therapeutic Targets in Asthma.

  2018cited by this paper
• The effects of PPARγ on the regulation of the TOMM40-APOE-C1 genes cluster.

  2017cited by this paper
• Old Maids: Aging and Its Impact on Microglia Function

  2017cited by this paper
• Metabolic and Inflammatory Adaptation of Reactive Astrocytes: Role of PPARs

  2017cited by this paper
• Advanced Age Alters Monocyte and Macrophage Responses

  2016cited by this paper
• Crosstalk between macrophages and astrocytes affects proliferation, reactive phenotype and inflammatory response, suggesting a role during reactive gliosis following spinal cord injury

  2015cited by this paper
• High‐wire act: the poised genome and cellular memory

  2015cited by this paper
• Personalized medicine: Time for one-person trials

  2015cited by this paper
• Lung disease as a determinant of cognitive decline and dementia

  2015cited by this paper
• Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease

  2015cited by this paper
• The dynamics of monocytes and microglia in Alzheimer’s disease

  2015cited by this paper
• Disease variants in genomes of 44 centenarians

  2014cited by this paper
• Exercise, APOE genotype, and the evolution of the human lifespan.

  2014cited by this paper
• Aging and cardiovascular diseases: the role of gene-diet interactions.

  2014cited by this paper
• Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes

  2014cited by this paper
• The forgotten APOE allele: a review of the evidence and suggested mechanisms for the protective effect of APOE ɛ2.

  2013cited by this paper
• Unraveling Genetic Origin of Aging-Related Traits: Evolving Concepts

  2013cited by this paper
• Evolutionary molecular medicine

  2012cited by this paper
• Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families

  2012cited by this paper
• Evolution of the human lifespan, past, present, and future: phases in the evolution of human life expectancy in relation to the inflammatory load.

  2012cited by this paper
• An APOE Haplotype Associated with Decreased ε4 Expression Increases the Risk of Late Onset Alzheimer's Disease

  2011cited by this paper
• Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease.

  2011cited by this paper
• Histone H3K27ac separates active from poised enhancers and predicts developmental state

  2010cited by this paper
• Comparative genomics of autism and schizophrenia

  2010cited by this paper
• METAL: fast and efficient meta-analysis of genomewide association scans

  2010cited by this paper
• HRAS1 and LASS1 with APOE are associated with human longevity and healthy aging

  2010cited by this paper
• Genetics Analysis Workshop 16 Problem 2: the Framingham Heart Study data

  2009cited by this paper
• Genetic association study on in and around the APOE in late-onset Alzheimer disease in Japanese.

  2009cited by this paper
• A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies

  2009cited by this paper
• Genetic association study on in and around the APOE in late-onset Alzheimer disease

  2009cited by this paper
• Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord

  2009cited by this paper
• Understanding the basis for the association of apoE4 with Alzheimer's disease: opening the door for therapeutic approaches.

  2009cited by this paper
• Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci.

  2008cited by this paper
• A Genotype-Based Approach to Assessing the Association between Single Nucleotide Polymorphisms

  2008cited by this paper
• PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties.

  2007cited by this paper
• Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's disease.

  2007cited by this paper
• Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association.

  2007cited by this paper
• Phagocytosis of Amyloid-β and Inflammation: Two Faces of Innate Immunity in Alzheimer's Disease

  2007cited by this paper
• Apolipoprotein E as a target for developing new therapeutics for Alzheimer’s disease based on studies from protein, RNA, and regulatory region of the gene

  2007cited by this paper
• Contrasting linkage-disequilibrium patterns between cases and controls as a novel association-mapping method.

  2006cited by this paper
• Genetics of longevity and aging.

  2005cited by this paper
• DEMOGRAPHY: Enhanced: Broken Limits to Life Expectancy

  2002cited by this paper
• Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease.

  2001cited by this paper
• Neuroinflammation and the genetics of Alzheimer’s disease: The search for a pro-inflammatory phenotype

  2001cited by this paper
• An Overview of the Health and Retirement Study

  1995cited by this paper
• Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

  1993cited by this paper
• The Cardiovascular Health Study: design and rationale.

  1991cited by this paper

• Next-generation sequencing study identifies the first genes associated with Alzheimer's disease in Bangladeshi population: The CARED study.

  2026cites this paper
• Blood-based AT(N) biomarkers for Alzheimer’s disease and frontotemporal lobar degeneration in Latin America

  2026cites this paper
• Lower hippocampal volume partly mediates the association between rs6859 in the NECTIN2 gene and Alzheimer's disease: new findings from causal mediation analysis of ADNI data.

  2026cites this paper
• Serotonergic Psychedelics as Epigenetic Modulators: A Paradigm Shift in Alzheimer's Disease Therapeutics.

  2026cites this paper
• Multivariable Mendelian randomization study supports the causal effects of circulating metabolites on frailty

  2025cites this paper
• Distinct gut microbiota profiles and network properties in older Korean individuals with subjective cognitive decline, mild cognitive impairment, and Alzheimer’s disease

  2025cites this paper
• Intersection of COVID-19 and Alzheimer's Disease: Genetic Insights and Neuropathological Consequences.

  2025cites this paper
• Trustworthy causal biomarker discovery: a multiomics brain imaging genetics-based approach

  2025cites this paper
• A Module-Level Polygenic Risk Score-Based NetWAS Framework for Identifying AD Genetic Modules Mediated by Amygdala: An ADNI Study

  2025cites this paper
• Resilience mechanisms underlying Alzheimer’s disease

  2025cites this paper
• APOE4, Alzheimer's and Periodontal Disease: A scoping review.

  2025cites this paper
• PolyGR-containing aggregates link with pathology and clinical features of Alzheimer’s disease

  2025cites this paper
• Integrative analysis of proteomic and MRI data reveals protein associations with brain imaging features in Alzheimer’s disease

  2025cites this paper
• Lower Hippocampal Volume Partly Mediates the Association Between rs6859 in the NECTIN2 Gene and Alzheimer’s Disease: New Findings from Causal Mediation Analysis of ADNI Data

  2025cites this paper
• Assessing polyomic risk to predict Alzheimer's disease using a machine learning model

  2024cites this paper
• Multi-modal imaging genetics data fusion by deep auto-encoder and self-representation network for Alzheimer's disease diagnosis and biomarkers extraction

  2024cites this paper
• Modeling genotype–protein interaction and correlation for Alzheimer’s disease: a multi-omics imaging genetics study

  2024cites this paper
• Network medicine-based epistasis detection in complex diseases: ready for quantum computing

  2024cites this paper
• BEATRICE: Bayesian fine-mapping from summary data using deep variational inference

  2024cites this paper
• Complex genetic interactions affect susceptibility to Alzheimer's disease risk in the BIN1 and MS4A6A loci

  2024cites this paper
• Comparison of Ensemble Techniques for Early Prediction of Alzhiemer Disease

  2024cites this paper
• Detection of pathogenic variants in Alzheimer’s disease related genes in Bulgarian patients by pooled whole-exome sequencing

  2023cites this paper
• The genetic landscape of basal ganglia and implications for common brain disorders

  2023influential citation
• Associations of Alzheimer’s disease with inpatient hospital costs and with quality-adjusted life years: evidence from conventional and Mendelian randomization analyses in the UK Biobank

  2023cites this paper
• Network medicine-based epistasis detection in complex diseases: ready for quantum computing

  2023cites this paper
• Incorporating multi-stage diagnosis status to mine associations between genetic risk variants and the multi-modality phenotype network in major depressive disorder

  2023cites this paper
• BEATRICE: Bayesian Fine-mapping from Summary Data using Deep Variational Inference

  2023cites this paper
• Biyoinformatik araçlar aracılığıyla insan APOE (Apolipoprotein E) genindeki yanlış anlamlı SNV'lerin değerlendirilmesi

  2023cites this paper
• Association of Alzheimer's Disease with Genetic Variants of Apolipoprotein E, Clusterin, TNF-α and IL-6 Among Elderly Saudis.

  2022cites this paper
• Association of APOE Serum Levels and APOE ε2, ε3, and ε4 Alleles with Optic Neuritis

  2022cites this paper
• The shared genetic architecture of modifiable risk for Alzheimer's disease: a genomic structural equation modelling study.

  2022cites this paper
• Genetic risk scores and dementia risk across different ethnic groups in UK Biobank

  2022cites this paper
• Alzheimer's Disease Prediction via the Association of Single Nucleotide Polymorphism with Brain Regions

  2021cites this paper
• The Genetic Architecture of Alzheimers Disease Risk: A Genomic Structural Equation Modelling Study

  2021cites this paper
• Gene-Environment interactions and stochastic variations in the Gero-Exposome.

  2021cites this paper
• Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping

  2021cites this paper
• Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease a systematic review.

  2021cites this paper
• Definitive roles of TOMM40-APOE-APOC1 variants in the Alzheimer's risk.

  2021cites this paper
• A Multi-Task Deep Feature Selection Method for Brain Imaging Genetics

  2021cites this paper
• Genetic and regulatory architecture of Alzheimer's disease in the APOE region

  2020cites this paper
• Haplotype architecture of the Alzheimer's risk in the APOE region via co‐skewness

  2020cites this paper
• The ApoE Locus and COVID-19: Are We Going Where We Have Been?

  2020cites this paper